Back

Cholinergic synaptic plasticity shapes resilience and vulnerability to tau

Onuska, K. M.; Devito, L. A.; Shanks, H. R.; Qi, Q.; Crooks, A. M.; Haast, R. A.; Andrews, T. S.; Williams, K. M.; Beraldo, F. H.; Qiu, T.; Fajardo-Valdez, A.; Wearn, A.; Turner, G. R.; Thiessen, J. D.; Fox, M. S.; Hicks, J. W.; Bussey, T. J.; Saksida, L. M.; Tremblay-Mercier, J.; Breitner, J. C.; Soucy, J.-P.; Poirier, J.; Villeneuve, S.; Prado, V. F.; Prado, M. A.; Spreng, R. N.; Schmitz, T. W.; for the PREVENT-AD Research Group,

2025-07-29 neuroscience
10.1101/2025.05.27.656174 bioRxiv
Show abstract

Synaptic dysfunction is a hallmark of Alzheimers disease (AD). Yet due to their plasticity, synapses may also adapt to early AD pathology. Here, we demonstrate that cholinergic neurons mount a presynaptic response to tau pathology in the living human brain. Using multi-tracer positron emission tomography in cognitively normal older adults at risk for AD, we observe that cholinergic neurons increase presynaptic vesicular acetylcholine transporter (VAChT) protein levels when colocalized to tau, but not amyloid. Notably, stronger VAChT responses predict preserved cognitive function over a decade. Whole-brain single-nucleus RNA sequencing in human and mouse tissue reveal that cholinergic neurons are enriched for a plasticity gene-network anchored to the microtubule-associated protein tau (MAPT) gene. In mice, forebrain-specific deletion of VAChT impairs cortical plasticity and hippocampal structural integrity. Overall, our findings identify cholinergic synaptic plasticity, and its failure, as a fundamental mechanism of resilience and vulnerability to tau in presymptomatic AD.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.